Rhythm Pharmaceuticals Stock (NASDAQ:RYTM), Quotes and News Summary

Q: What sector and industry does Rhythm Pharmaceuticals (RYTM) operate in?

Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rhythm Pharmaceuticals Stock (NASDAQ: RYTM) stock price, news, charts, stock research, profile.

Open	$39.390
Close	-
Volume / Avg.	136.068K / 598.942K
Day Range	39.190 - 41.850
52 Wk Range	15.500 - 52.570
Market Cap	$2.445B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	25.99%
Days to Cover	16.16

Recent News

Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

Avi Kapoor

Rare Genetic Diseases Of Obesity-Focused Rhythm Pharma's Bardet-Biedl Syndrome Drug Meets Primary Goal In Pediatric Trial

During the R&D event for investors, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) released new topline data from its Phase 3 pediatrics trial evaluating one year of setmelanotide in patients aged two and below six years with Bardet-Biedl syndrome (BBS) or proopiomelanocortin (POMC) or leptin recep

Vandana Singh

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Jan

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Rhythm Pharmaceuticals Inc.

Sector

Health Care

Industry

Biotechnology

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commerci...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rhythm Pharmaceuticals (RYTM) stock?

You can purchase shares of Rhythm Pharmaceuticals (NASDAQ: RYTM) through any online brokerage.

View our list of the best stock brokerages.

Who are Rhythm Pharmaceuticals's (RYTM) competitors?

Other companies in Rhythm Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX), PTC Therapeutics (NASDAQ:PTCT) and Arrowhead Pharma (NASDAQ:ARWR).

What is the target price for Rhythm Pharmaceuticals (RYTM) stock?

The latest price target for Rhythm Pharmaceuticals (NASDAQ: RYTM) was reported by Wells Fargo on Thursday, April 18, 2024. The analyst firm set a price target for 52.00 expecting RYTM to rise to within 12 months (a possible 27.91% upside). 17 analyst firms have reported ratings in the last year.

Current Stock Price for Rhythm Pharmaceuticals (RYTM)?

The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $40.655 last updated Today at April 23, 2024 at 11:57 AM EDT.

Does Rhythm Pharmaceuticals (RYTM) pay a dividend?

There are no upcoming dividends for Rhythm Pharmaceuticals.

When is Rhythm Pharmaceuticals (NASDAQ:RYTM) reporting earnings?

Rhythm Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Rhythm Pharmaceuticals (RYTM) going to split?

There is no upcoming split for Rhythm Pharmaceuticals.

What sector and industry does Rhythm Pharmaceuticals (RYTM) operate in?

Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-